Get to know the ready-made immunity to protect against ‘RSV virus’ in children in high-risk groups.
The RSV virus is responsible for more than 60% of acute respiratory infections in children. Recently, AstraZeneca’s RSV ready-made immune system Received approval to register a drug formula in Thailand. For use in prevention among children at high risk. RSV virus It is an important cause of lower respiratory tract infections In children around the … Read more